James Maitlall, MD

Researchers compared the clinical features of patients with early- vs late-onset systemic lupus erythematosus.

Researchers determined the effect of measures of patient preferences, including readiness/willingness and expectations, on total knee arthroplasty outcomes.

Researchers compared the safety and efficacy of the different biologic DMARDs in the treatment of immune checkpoint inhibitor-associated inflammatory arthritis.

Researchers studied the mental health outcomes of patients with rheumatic disease during the COVID-19 pandemic.

Researchers sought to develop a quick, straightforward risk score to categorize mortality post-femur fracture.

Researchers studied the effect of preexisting rheumatoid arthritis on risk for mortality and immune-related adverse events among those receiving immune checkpoint inhibitors.

Using data from the MONARCH and OLE trials, researchers studied the effect of switching to sarilumab among patients with RA with a partial response to adalimumab.

Researchers evaluated the differential diagnostic spectrum among patients with suspected Behçet syndrome in low prevalence regions.

Researchers sought to compare MIS-C treatments in children, as well as determine the likelihood of cardiac complications.

Researchers studied the association of axial spondyloarthritis and psoriatic arthritis with the rate of elective and emergency cesarean sections.

Researchers evaluated the association between the Healthy, Hunger-Free Kids Act of 2010 and body mass index in children for evidence of effectiveness.

Researchers studied the prevalence of metabolic syndrome in patients with antiphospholipid syndrome as well as its association with clinical and laboratory features.

A cross-sectional study was conducted to identify distinct phenotype clusters and subtypes of patients with gout and related comorbidities.

Researchers determined the effect of diabetes on risk for end-stage kidney disease among patients with systemic lupus erythematosus.

Researchers studied the obstetric outcomes and rehospitalization rates among patients with rheumatoid arthritis and systemic lupus erythematosus, and their infants.